Skip to main content
MyCapitol LogoMyCapitol

HR 7828 · 117th Congress

PRICED Act

This bill would speed up when cheaper generic versions of expensive biologic drugs can hit the market. Right now, when a pharmaceutical company develops a brand-name biologic drug—these are complex medications made from living cells, like many cancer treatments and biologics for arthritis—they get 12 years of exclus…

Sponsor
Schakowsky, Janice D. (D-IL)
Introduced
2022-05-18
Policy area
Health
Latest action
Referred to the House Committee on Energy and Commerce.

Digging through Congress... 🔍